Venglustat

未知生产厂商

Venglustat is under investigation in clinical trial NCT01674036 (Safety, Tolerability and Pharmacokinetics of Genz-682452 in Healthy Men).

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

概览

Venglustat is under investigation in clinical trial NCT01674036 (Safety, Tolerability and Pharmacokinetics of Genz-682452 in Healthy Men).

技术标识符

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

PHARMACEUTICAL COMPOSITIONS COMPRISING VENGLUSTAT
EP 4185267 A1申请人: GENZYME CORP优先权: 2020
EP
US
WO
5 件公开
VENGLUSTAT FOR USE IN METHODS FOR REDUCING DISEASE RELATED BIOMARKER LEVELS IN PATIENTS WITH GANGLIOSIDE STORAGE DISORDERS
- WO 2025219951 A1
  申请人: GENZYME CORP优先权: 2024
  WO
- WO 2025219952 A1
  申请人: GENZYME CORP优先权: 2024
  WO
VENGLUSTAT AS AN INHIBITOR OF GLUCOSYLCERAMIDE SYNTHASE IN SUBJECTS HAVING HEPATIC IMPAIRMENT
WO 2025262570 A1申请人: GENZYME CORP优先权: 2024
WO